Literature DB >> 35801740

High-quality nursing care on psychological disorder in ovarian cancer during perioperative period: A systematic review and meta-analysis.

Peng Jin1, Li-Li Sun, Bin-Xin Li, Mei Li, Wei Tian.   

Abstract

BACKGROUND: This study aimed to explore the effect of high-quality nursing care (HQNC) on psychological disorder in patients with ovarian cancer (OC) during the perioperative period (PPP).
METHODS: A literature search was performed at the Cochrane Library, PUBMED, Excerpt Medica Database, China National Knowledge Infrastructure, and Chinese Biomedical Literature Database from their inception until March 1, 2022. Two authors independently performed study selection, data collection, and methodological quality evaluation. The outcomes were anxiety (as measured by the Self-rating Anxiety Scale), depression (as measured by Self-rating Depression Scale), length of hospital stay, and rate of patient satisfaction.
RESULTS: Eight trials involving 742 patients with OC were included in this study. Results of the data analysis showed that patients who received HQNC had a more promising effect on anxiety relief (mean difference, -9.00; random 95% confidence interval, -11.36 to -6.63; P < .001) and depression decrease (mean difference, -7.62; random 95% confidence intervals, -8.45 to -6.78; P < .001) than patients who underwent routine nursing care.
CONCLUSION: This study summarized the latest evidence of HQNC on psychological disorder relief in patients with OC during perioperative period. These findings showed that HQNC may benefit patients with anxiety and depression.
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2022        PMID: 35801740      PMCID: PMC9259176          DOI: 10.1097/MD.0000000000029849

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


1. Introduction

Ovarian cancer (OC) is one of the most common gynecological malignancies in females,[ accounting for 2.5% of all cancers in the female population.[ It also ranks as the fifth leading cause of cancer-related deaths in women in the United States. A study reported that approximately 13,770 patients died of OC, and 21,410 cases were newly diagnosed in 2021 in the United States.[ Surgery is a main effective modality of clinical treatment for patients with OC and can greatly improve the prognosis and survival time.[ However, postoperative complications, such as anxiety and depression, are inevitable.[ Studies reported that routine nursing care (RNC)-benefited OC patients underwent surgery. Patients were instructed health education, essential knowledge of ovary, and guidance for diet, medication, and physical rehabilitation. To further relieve psychological disorders in patients with OC during the perioperative period (PPP), high-quality nursing care (HQNC) is reported to relieve anxiety and depression.[ In addition to RNC, HQNC also included psychological counseling and advice. Previous clinical studies have investigated the psychological effects of HQNC in the treatment of patients with OC during PPP.[ However, no systematic review or meta-analysis has explored this issue. Therefore, this systematic review and meta-analysis comprehensively assessed HQNC on psychological disorders relief in patients with OC during PPP.

2. Methods

2.1. Literature search

A search was performed on the Cochrane Library, PUBMED, Excerpt Medica Database, China National Knowledge Infrastructure, and Chinese Biomedical Literature Database databases from their inception until March 1, 2022, to identify eligible trials. In addition, other literature sources were searched. We carried out literature search using keywords of “ovarian cancer,” “ovarian neoplasms,” “genital neoplasms, female,” “cancer,” “neoplasms,” “carcinoma,” “malignant tumor,” “anxiety,” “psychological disorder,” “depressive symptoms,” “emotional depression,” “mood,” “stress,” “distress,” “surgery,” “surgical resection,” “high-quality nursing care,” “advanced care,” “intensive care,” “randomized controlled trial,” “clinical trial,” and “controlled study.” Detailed search strategy of PUBMED was presented in Table 1. This study included randomized controlled trials (RCTs) investigating the psychological effects of HQNC in patients with OC during PPP.
Table 1

Detailed search strategy in PUBMED.

NumberSearch terms
1ovarian cancer
2ovarian neoplasms
3genital neoplasms, female
4cancer
5neoplasms
6carcinoma
7malignant tumor
8Or 1-7
9surgery
10surgical resection
11operation
12Or 9-11
13psychological disorder
14depressive symptoms
15anxiety
16emotional depression
17mood
18stress
19distress
20Or 13-19
21high-quality nursing care
22advanced care
23intensive care
24Or 21-23
25case-control study
26observational study
27clinical trial
28randomized controlled trial
29Or 25-28
308 AND 12 AND 20 AND 24 AND 29
Detailed search strategy in PUBMED.

2.2. Study selection

After a comprehensive literature search, all records were identified using the reference management software to remove duplicate studies. Two authors (P.J. and L.-L.S.) independently screened titles and abstracts of remaining literature, and the full texts of potential articles were read cautiously. All eligible studies were included against eligibility criteria. Discrepancies were resolved by consulting a third experienced author (W.T.).

2.3. Eligibility criteria

Inclusion criteria: RCTs evaluating the psychological effect of HQNC in patients with OC during PPP were considered. All patients who underwent surgery were diagnosed with OC and were complicated by anxiety and depression. Patients in the treatment group received HQNC, whereas those in the control group received RNC. The exclusion criteria were as follows: irrelevant studies of duplicate, review, noncontrolled studies, and case reports; and studies that did not involve HQNC, incomplete data, not RCT, and combined therapy.

2.4. Outcome measurement

The primary outcomes were anxiety and depression. Anxiety was measured using the Self-rating Anxiety Scale (SAS), and depression was assessed using the Self-rating Depression Scale (SDS).[ SAS consists of 20 subscales, and each item scores from 1 to 4, with a higher score indicating more serious of anxiety condition.[ SDS comprises of 20 subscales, and each one ranges from 1 to 4, with a higher score suggesting worse of depression.[ The secondary outcomes were length of hospital stay (LHS) and rate of patient satisfaction (RPS).

2.5. Data extraction

Two authors (P.J., L.-L.S.) independently retrieved relevant information from the selected primary trials using a previously established data extraction form. The following data were sought: first author, year of publication, general patient characteristics, sample size, types of intervention and comparison, and primary and secondary outcomes. The differences between the two authors were resolved by consulting a third experienced author (W.T.).

2.6. Risk of bias assessment

All included trials were evaluated for methodological quality using the Cochrane risk-of-bias tool through seven domains. Each was further defined as having a low, unclear, or high risk of bias. The analysis was performed by two independent authors (B.-X.L., M.L.). The divergences between the two authors were resolved by a third author (W.T.) through discussion.

2.7. Statistical Analysis

All data analyses were conducted using RevMan 5.3 software (The Nordic Cochrane Centre for The Cochrane Collaboration, Copenhagen, Denmark). All continuous data were presented as mean difference (MD) and 95% confidence interval (CI), and all dichotomous data were presented as odds ratios and 95% CI. Statistical heterogeneity of pooled data was checked using I² index with I² < 50%, indicating reasonable heterogeneity, and I² ≥ 50%, indicating substantial heterogeneity. A fixed-effects model was used to pool the data with reasonable heterogeneity, and a random-effects model was used to synthesize the data with significant heterogeneity.

3. Results

3.1. Records of study selection

In total, 142 citations were identified (Fig. 1). Titles and abstracts were scanned, and 89 studies were excluded because of the irrelevant records, including reviews, case reports, uncontrolled studies, and not specifically related to the topic. We examined the full text of the 28 remaining articles. Twenty studies were eliminated because they did not involve HQNC, incomplete data, and combined therapy, and were not RCT. Finally, 8 trials were eligible for data analysis (Fig. 1).
Figure 1.

Diagram flow of study selection. RCT = randomized controlled trial.

Diagram flow of study selection. RCT = randomized controlled trial.

3.2. Study characteristics

Eight trials including 742 patients focusing on HQNC for anxiety and depression in patients with OC during PPP were included in this study (Table 2). The sample sizes ranged from 50 to 200 women. All 8 studies were prospective RCTs. The general characteristics of patients with OC in those studies are summarized in Table 2.
Table 2

General characteristics of included studies.

StudyNo. of patients (T/C)Age (yr, T/C)InterventionControlOutcomes
Chen[20]59/59T: 44 ± 10; C: 44 ± 10HQNCRNCSAS; SDS
Cui[21]40/40T: 44.3 ± 2.1; C: 44.2 ± 2.2HQNCRNCSAS; SDS
Gao and Li[22]47/47T: 51 ± 12; C: 51 ± 12HQNCRNCSAS; SDS
Jiao et al[23]34/34T: 55 ± 7.5; C: 56.6 ± 6.2HQNCRNCSAS
Wang[24]34/34T: 56.2 ± 2.5; C: 56.6 ± 2.4HQNCRNCSAS; SDS
Wang[25]34/34T: 41.4 ± 10.3; C: 42.5 ± 11.7HQNCRNCSAS; SDS; LHS; RPS
Xu[26]25/25T: 51.7 ± 7.6; C: 52.2 ± 6.5HQNCRNCSAS; SDS
Zhang et al[16]100/100T: 44.9 ± 1.2; C: 45.6 ± 1.4HQNCRNCSAS; SDS

C = control group, HQNC = high-quality nursing care, LHS = length of hospital stay, NR = not reported, RNC = routine nursing care, RPS = rate of patient satisfaction, SAS = Self-rating Anxiety Scale, SDS = Self-rating Depression Scale, T = treatment group.

General characteristics of included studies. C = control group, HQNC = high-quality nursing care, LHS = length of hospital stay, NR = not reported, RNC = routine nursing care, RPS = rate of patient satisfaction, SAS = Self-rating Anxiety Scale, SDS = Self-rating Depression Scale, T = treatment group.

3.3. Study quality assessment

According to the Cochrane risk-of-bias tool, four studies reported random sequence generation,[ whereas the other four trials failed to report it sufficiently[ (Fig. 2). As for allocation concealment and blinding to participants, investigators, and outcome assessors, none of the 8 studies reported sufficiently[ (Fig. 2). As for incomplete outcome data, all studies reported outcomes comprehensively,[ except one study[ (Fig. 2). All 8 trials reported selective reporting and other biases sufficiently[ (Fig. 2).
Figure 2.

Risk of bias summary.

Risk of bias summary.

3.4. Data analysis of anxiety

All 8 studies with 742 patients assessed the effect of HQNC on anxiety relief in patients with OC during PPP. Statistically significant differences were found in SAS (MD, −9.00; random 95% CI, −11.36 to −6.63; P < .001; I² = 95%; Table 3, Fig. 3).
Table 3

Qualitative synthesis of included trials.

Outcome or subgroupStudiesParticipantsStatistical methodEffect estimate
1.1 SAS8742Mean difference (IV, random, 95% CIs)−9.00 (−11.36 to −6.63)
1.2 SDS7674Mean difference (IV, random, 95% CIs)−7.62 (−8.45 to −6.78)
1.3 LHS164Mean difference (IV, fixed, 95% CIs)−5.50 (−7.12 to −3.88)
1.4 RPS164Odds ratio (M-H, fixed, 95% CIs)34.77 (1.95–621.45)

CI = confidence interval, LHS = length of hospital stay, RPS = rate of patient satisfaction, SAS = Self-rating Anxiety Scale, SDS = Self-rating Depression Scale.

Figure 3.

Data analysis of anxiety. CI = confidence interval, IV, inverse variance, SD = standard deviation.

Qualitative synthesis of included trials. CI = confidence interval, LHS = length of hospital stay, RPS = rate of patient satisfaction, SAS = Self-rating Anxiety Scale, SDS = Self-rating Depression Scale. Data analysis of anxiety. CI = confidence interval, IV, inverse variance, SD = standard deviation.

3.5. Data analysis of depression

Seven studies with 674 participants evaluated the effect of HQNC on depression reduction in patients with OC during PPP. There were significant differences in SDS (MD, −7.62; random 95% CI, −8.45 to −6.78; P < .001; I²=58%; Table 3 and Fig. 4).
Figure 4.

Data analysis of depression. CI = confidence interval, IV, inverse variance, SD = standard deviation.

Data analysis of depression. CI = confidence interval, IV, inverse variance, SD = standard deviation.

3.6. Report of LHS and RPS

Only one study reported the effect and safety of HQNC for patients with anxiety and depression during PPP on LHS (MD, −5.5; fixed 95% CI, −7.12 to −3.88; Table 3) and RPS (MD, 34.77; fixed 95% CI, 1.95–621.45; Table 3).

4. Discussion

OC is one of the most lethal gynecological cancers, resulting in a high incidence of cancer-related deaths in the female population. Surgery is the most effective treatment for such disorder.[ Although a large number of patients with OC benefit from surgery, it is accompanied by a variety of complications, such as anxiety and depression.[ Previous studies have reported that HQNC has potential to reduce anxiety and depression in patients with cancer during PPP.[ Furthermore, a variety of clinical trials have focused on the management of psychological disorders in patients with OC during PPP.[ However, no study has addressed this topic systematically and comprehensively. Therefore, to the best of our knowledge, this is the first systematic review and meta-analysis to comprehensively investigate the psychological effects of HQNC on patients with OC during PPP. In the present study, we included eight studies with 742 patients. We pooled and analyzed the data on anxiety and depression. The results showed that the psychological effects of HQNC were superior to those of RNC in terms of anxiety relief (MD, −9.00; random 95% CI, −11.36 to −6.63; P < .001) and depression reduction (MD, −7.62; random 95% CI, −8.45 to −6.78; P < .001). Only one study investigated LHS and RPS, and no data were synthesized. The strengths and limitations of this study were also investigated. As for strength, this study first clarified the psychological effects of HQNC in patients with OC during PPP. In addition, this study also provided a comprehensive and systematic insight into the potential impact of anxiety and depression management using direct comparisons of HQNC and RNC. In terms of limitations, overall methodological quality of the 8 included trials is still not satisfactory, with 4 studies reporting insufficient randomization details, and none of the trials reported detailed information on allocation and blinding. The sample sizes of some studies were small, which may have affected the results. In addition, all included trials were conducted in China and published in Chinese journals, which may cause risk of reporting bias based on the location and region. Finally, there were an insufficient number of included studies that focused on LHS and RPS.

5. Conclusion

This study showed that HQNC had a better effect on anxiety and depression relief in patients with OC during PPP than that of RNC. However, the overall methodological quality of included studies was found to be low. Further similar studies with high-quality RCTs are required to validate the present conclusions.

Author contributions

Conceptualization: Peng Jin and Wei Tian. Data curation: Ping Liu, Li-Li Sun, Bin-Xin Li, and Wei Tian. Formal analysis: Peng Jin, and Ping Liu. Investigation: Wei Tian. Methodology: Wei Tian, Li-Li Sun, Bin-Xin Li, Mei Li, and Wei Tian. Supervision: Wei Tian. Validation: Wei Tian. Writing-original draft: Peng Jin. Writing-review & editing: Wei Tian.
  22 in total

1.  Recent progress in the diagnosis and treatment of ovarian cancer.

Authors:  Danijela Jelovac; Deborah K Armstrong
Journal:  CA Cancer J Clin       Date:  2011-04-26       Impact factor: 508.702

2.  Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?

Authors:  Vasileios D Sioulas; Maria B Schiavone; David Kadouri; Oliver Zivanovic; Kara Long Roche; Roisin O'Cearbhaill; Nadeem R Abu-Rustum; Douglas A Levine; Yukio Sonoda; Ginger J Gardner; Mario M Leitao; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2017-02-21       Impact factor: 5.482

3.  Surgery Improves Relapsed Ovarian Cancer Survival.

Authors:  Anita Slomski
Journal:  JAMA       Date:  2022-01-25       Impact factor: 56.272

4.  Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Alexi A Wright; Kari Bohlke; Deborah K Armstrong; Michael A Bookman; William A Cliby; Robert L Coleman; Don S Dizon; Joseph J Kash; Larissa A Meyer; Kathleen N Moore; Alexander B Olawaiye; Jessica Oldham; Ritu Salani; Dee Sparacio; William P Tew; Ignace Vergote; Mitchell I Edelson
Journal:  J Clin Oncol       Date:  2016-08-08       Impact factor: 44.544

5.  Perioperative administration of propranolol to women undergoing ovarian cancer surgery: A pilot study.

Authors:  Hye-In Jang; Soo-Hyun Lim; Yoo-Young Lee; Tae-Joong Kim; Chel Hun Choi; Jeong-Won Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  Obstet Gynecol Sci       Date:  2017-03-16

6.  A retrospective pilot study of high-quality nursing care for cervical cancer.

Authors:  Ya-Hui Fu; Zhao-Rong Wang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

7.  Effects of high-quality nursing care for patients with lung cancer during the perioperative period: A protocol of systematic review of randomized controlled trials.

Authors:  Xia Yu; Jun Liu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

8.  Effect of Psychological Intervention Combined with Dietary Guidance on Quality of Life and Long-Term Efficacy of Bushen Quyu Decoction in Treatment of Patients with Advanced Ovarian Cancer.

Authors:  Dan Liu; Guangwen Shi; Chao Yin; Zhendong Liu; Aixia Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-25       Impact factor: 2.629

9.  Screening for anxiety and depression: reassessing the utility of the Zung scales.

Authors:  Debra A Dunstan; Ned Scott; Anna K Todd
Journal:  BMC Psychiatry       Date:  2017-09-08       Impact factor: 3.630

10.  Worldwide incidence and mortality of ovarian cancer and Human Development Index (HDI): GLOBOCAN sources and methods 2018.

Authors:  Zaher Khazaei; Seyedeh Mahdieh Namayandeh; Reza Beiranvand; Hasan Naemi; Seyyede Maryam Bechashk; Elham Goodarzi
Journal:  J Prev Med Hyg       Date:  2021-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.